DJ-1 was first identified as an activated ras-dependent oncogene. DJ-1 is related to male fertility, and its expression in sperm decreases in response to exposure to a number of reproductive toxicants. DJ-1 has been associated with the onset of familial Parkinson's disease (PD) in humans, and has been found to have activity against oxidative damage by eliminating reactive oxygen species (ROS). In this study, we investigated the role of DJ-1 in oxidative stresses by administration of bisphenol A (BPA), which has been reported to induce oxidative stress in rodents, to male mice and cultured cells. In male mice, we found that BPA significantly increased the expression level of DJ-1 in the sperm and brain. In cultured Neuro2a and GC1 cells, we found that BPA induced ROS production and significantly compromised mitochondrial function concomitant with elevated expression and oxidization of DJ-1. DJ-1 was found to maintain the complex I activity against BPA-induced oxidative stress after the localization in mitochondria. The results showed that DJ-1 plays a role in the prevention of mitochondrial injury-induced cell death.
DJ-1 was first identified by our group as a novel candidate of the oncogene product that transformed mouse NIH3T3 cells in cooperation with activated ras (Nagakubo et al., 1997) . DJ-1 is 20-kDa protein comprising 189 amino acid residues that is expressed in various tissues with particularly high levels of expression in the testis, sperm, and brain (Bandopadhyay et al., 2004; Wagenfeld et al., 2000) . DJ-1 was later found to be a positive regulator of the androgen receptor (Niki et al., 2003; Taira et al., 2004a; Takahashi et al., 2001 ) and p53 (Shinbo et al., 2005a) and to be a negative regulator of PTEN tumor suppressor (Kim et al., 2005) . DJ-1 has also been reported to be related to infertility of rats and mice and to participate in fertilization for sperm to penetrate into the zonae pellucida of eggs (Klinefelter et al., 2002; Okada et al., 2002; Wagenfeld et al., 1998 Wagenfeld et al., , 2000 Welch et al., 1998; Yoshida et al., 2003) . Recently, DJ-1 has been shown to be responsible for onset of familial Parkinson's disease (PD), PARK7 (Bonifati et al., 2003) , and 11 mutations in familial and sporadic forms of PD have been reported (Abou-Sleiman et al., 2003; Hague et al., 2003) .
Reactive oxygen species (ROS), including superoxide (O ÿ 2 ), hydrogen peroxide (H 2 O 2 ), and hydroxyl radical (HO ÿ ), damage various cell components such as unsaturated lipids, proteins, and nucleic acids. Oxidative stress is caused by ROS in cells in which large amounts of ROS are produced by alternative activities of scavenger proteins or by dysfunction of the mitochondrial respiratory chain pathway with reduction of complex I activity. Complex I (NADH:ubiquinone oxidoreductase) catalyses the first step in the mitochondrial electron transport chain, by which electrons from the oxidation of NADH are used to convert oxygen to water, the energy liberated being trapped in ATP formation and ultimately used as the body's energy source. Oxidation of nucleic acid, lipid, and protein is thought to result in the onset of various diseases, including cancer, infertility, and neurodegenerative diseases such as PD (Agarwal et al., 2003; Benhar et al., 2002; Golden et al., 2002; Rego and Oliveira, 2003) . Expression of DJ-1 and oxidation of DJ-1 have been shown to be induced in cells that had been administered ROS-inducing chemicals (Kinumi et al., 2004; Mitsumoto et al., 2001; Mitsumoto and Nakagawa, 2001) , and abnormal oxidative forms of DJ-1 have been found in some patients with sporadic forms of PD (Bandopadhyay et al., 2004) . We and other groups have shown that some DJ-1 is located in mitochondria in addition to the cytoplasm and nucleus Shinbo et al., 2005a; Zhang et al., 2005) and that translocation of DJ-1 to mitochondria was stimulation by oxidative stress (Blackinton et al., 2005; Jin et al., 2005; Li et al., in press) . Precise functions of DJ-1 in mitochondria are, however, not clear.
In addition to its transcriptional activity as a coactivator, we previously reported that DJ-1 plays a role in the anti-oxidative stress reaction, in which reactive oxygen species were eliminated in vitro and in vivo by oxidizing DJ-1 itself, and that mutations of DJ-1, including various mutations found in PD patients, lead to oxidative stress-induced cell death (Taira et al., 1 To whom correspondence should be addressed at Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, 2004b; Yokota et al., 2003) . Other groups also reported anti-oxidative activity of DJ-1 Martinat et al., 2004; Shendelman et al., 2004) . It has been shown that, of three cysteines at amino acid numbers 46, 53, and 106 in DJ-1, C106 was first oxidized by addition of SO 3 H or SO 2 H, followed by oxidation of C46 and C53 with a dose of H 2 O 2 added to cultured cells (Kinumi et al., 2004) , and that C106 was required for DJ-1 to exert activity against oxidative stress Martinat et al., 2004; Shendelman et al., 2004; Taira et al., 2004b; Takahashi-Niki et al., 2004) . In addition to oxidation of DJ-1, DJ-1 has been reported to be conjugated with SUMO-1 on a lysine residue at amino-acid number 130 (K130) (Shinbo et al., in press ). Sumoylation of DJ-1 at K130 has been found to essential for DJ-1 to exert its full activities, including activities for rasdependent transformation, cell growth stimulation, and antioxidative stress (Shinbo et al., in press ). Loss of these functions of DJ-1 is therefore thought to lead to the onset of PD.
Some endocrine disruptors (EDs) such as lindane, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and bisphenol A (BPA) have been shown to induce oxidative stress in the brain, liver, kidney, testis, and epididymal sperm in rodents (Bindhumol et al., 2003; Chitra et al., 2003; Junqueira et al., 1988; Kabuto et al., 2003 Kabuto et al., , 2004 Latchoumycandane et al., 2002; Stohs et al., 1991) . Furthermore, BPA and some bisphenols have been reported to reduce mitochondrial function (Nakagawa and Toyama, 2000) , but the precise mechanisms underlying these phenomena have not been elucidated.
In this study, we analyzed the effect of DJ-1 on BPA-induced cell death. The results showed that BPA induced oxidative stress in mitochondria and that DJ-1 plays a role as a scavenger of ROS to prevent cell death.
MATERIALS AND METHODS
Animals and treatment. C57BL/6 male mice at 5 weeks of age were purchased from Sankyo Laboratory, Sapporo, Japan. The mice were acclimated to the laboratory for 1 week prior to the experiments and then divided into the following three groups: one group of mice at 6 weeks of age orally administered daily bisphenol A (BPA, Wako) dissolved in corn oil at 10 or 100 lg/kg body weight for 1 or 2 weeks, one group of mice given corn oil (5 ml/kg) alone for the same period, and one group of mice not treated. At 24 h after last administration, the mice were killed, and their brain and cauda epididymides were removed. To purify sperm, sperm was extracted from the cauda epididymes of male mice with a syringe, transferred to a tube containing 5% Ficoll in phosphate-buffered saline (PBS), and centrifuged at 14,000 rpm for 5 min. The pellet fraction containing purified sperm and brain were stored at ÿ80°C until use. All animal experiments were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and the protocols were approved by the Committee for Animal Research at Hokkaido University.
Cells and treatment. Mouse Neuro2a and GC1 cells were purchased from American Tissue Culture Collection. All the cells used in this study were cultured in Dulbecco's modified medium supplemented with 10% calf serum. Cells were then administered various concentrations of BPA dissolved in dimethyl sulfoxide (DMSO) for 24 or 48 h. As a vehicle control, 0.1% DMSO was added to the medium.
Western blotting and isoelectric focusing. Proteins were prepared from whole tissues or cultured cells for Western blot analysis as follows. The brain and sperm were homogenized in 20 mM phosphate buffer (pH 7.5) containing 150 mM NaCl, 1% NP-40, 1 mM EDTA, 1 mM PMSF, and protease inhibitors. Cultured cells were homogenized in a buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 5 mM EDTA, 1 mM PMSF, and protease inhibitors. Extracts were then centrifuged at 12,000 rpm for 5 min, and their supernatants were used. To analyze proteins in mitochondria by Western blotting, cells were homogenized in a buffer containing 0.25 M sucrose, 10 mM Tris-HCl (pH 7.3), and 1 mM EDTA and then centrifuged at 1000 3 g for 10 min. Their supernatant fractions were then centrifuged at 12,000 3 g for 15 min, and the pellet fractions (mitochondrial-enriched fractions) were suspended in a buffer containing 0.25 M sucrose, 10 mM Tris-HCl (pH 7.3), 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and 0.1 mM PMSF. Concentration of mitochondria protein was measured by using a BCA protein assay kit (PERBIO), and 20 lg of mitochondria protein was used for Western blotting. For isoelectric focusing, cells were homogenized in PBS containing 2% NP-40 and centrifuged at 12,000 rpm for 5 min, and their supernatants were used. Proteins in these extracts were then separated in a 12.5% polyacrylamide gel containing SDS or in an isoelectric focusing gel of pH 5-8, transferred onto nitrocellulose membranes, and reacted with an anti-DJ-1 antibody, which was an affinity-purified rabbit anti-DJ-1 polyclonal antibody described previously (Nagakubo et al., 1997) , an anti-complex I monoclonal antibody cocktail (Mito Science), or an anti-actin antibody (Chemicon). The proteins on the membranes were then reacted with IRDye800-or Alexa Fluor680-conjugated secondary antibodies followed by visualization using an infrared imaging system (Odyssey, LI-COR).
Flow cytometric analysis. Nero2a and GC1 cells were mixed with 10 lM 2#,7#-dichlorodihydrofluorescein diacetate (DCFH-DA) (Molecular Probes) or 2-[6-( 4#-hydroxy)phenoxy-3H-xanthen-3-on-9-yl]benzoic acid (HPF) (Daiichi Kagaku) in Hank's solution containing 10 mM HEPES-KOH (pH 7.4) for 30 min in the dark, and their fluorescences were measured using a FACScan flow cytometer (Becton-Dickinson) with excitation at 488 and emission at 530 nm. The amounts of fluorescences were also quantified using a ''CELL QUEST'' program as a value of ''median''.
Indirect immunofluorescence. Cells were mixed with 500 nM MitoTracker-Green (Molecular Probes) for 40 min and then reacted with 5 lM MitoSOX Red (Molecular Probes) for 10 min. The cells were then fixed with a solution containing 4% paraformaldehyde and reacted with an affinitypurified rabbit anti-DJ-1 polyclonal antibody. The cells were then reacted with a Cy-5-conjugated anti-rabbit IgG and observed under a confocal laser fluorescent microscope.
siRNA. The nucleotide sequences for siRNAs targeting DJ-1 were 5#-CCUUGCUAGUAGAAUAAACdTdT-3# and 3#-dTdTGGAACGAUCAUCU-UAUUUG-5# for upper and lower strands, respectively. siRNA-targeting luciferase was purchased from Greiner (Japan). Twenty nM siRNA was transfected into cells using Lipofectamine 2000 (Invitrogen) according to the supplier's manual.
Complex I activity. A mitochondria-enriched fraction was prepared as described above. Seventy lg of mitochondria protein and 0.05 mM ubiquinone 1 were added to 35 mM phosphate buffer (pH 7.4) containing 2.65 mM sodium cyanide, 5 mM MgCl 2 , 1 mM EDTA, 1 mg/ml bovine serum albumin, and 2 lg/ml antimycin in a final volume of 0.48 ml. After incubation of the mixture at 37°C for 2 min, 0.02 ml of 5 mM NADH solution was added to the reaction mixture, and decrease in absorbance was measured by a spectrophotometer at 340 nm for 4 min.
Cell viability assay. Cell viability was measured by a methyl thiazolyl tetrazolium (MTT) assay using a cell counting kit 8 (DOJINDO).
RESULTS

Change in DJ-1 Expression in Male Mice and Cultured Cells
Caused by BPA Administration
Since it has been reported that concentrations of extracted BPA from food such as anchovy, herring, and sardine and from saliva are 10-50 lg/g liq and 90-931 lg/h, respectively, (Biles et al., 1999; Olea et al., 1996) , we chose 10 and 100 lg/kg body weight/day of BPA as the low and high concentrations, respectively. Although these concentrations of BPA to mice are relatively high, these concentrations have been used in several studies to examine the molecular mechanism of BPA action (see recent references, Al-Hiyasat et al., 2004; Nikaido et al., 2004; Toyama et al., 2004) . These two concentrations of BPA dissolved in corn oil were administered orally to C57BL/6N male mice for 1 or 2 weeks, and corn oil alone was administered to mice as a vehicle control. Another control group consisted of untreated mice. Expressions of DJ-1 in the brain and sperm after administration of BPA were then examined by Western blotting (Figs. 1A and 1B, upper panels), and intensities of bands were measured using an infrared imaging system (Figs. 1A and 1B, lower panels). The results showed that expression levels of DJ-1 in the brain and sperm were significantly increased over a period of 2 weeks by 1.5-to 2-fold compared to those in the vehicle control in the case of administration of high-dose BPA. In the case of administration of low-dose BPA, however, there was little change in DJ-1 expression. These results indicate that BPA stimulates DJ-1 expression in mice.
To investigate the effect of BPA on DJ-1 expression in vitro, BPA dissolved in DMSO was administered to cultured mouse Neuro2a and GC1 cells, cells that originate from neuronal cells and spermatogonia immortalized with p53, respectively. Viabilities of Neuro2a and GC1 cells in the presence of BPA were first determined by an MTT assay ( Fig. 2A) . At 48 h after BPA administration, viabilities of Neuro2a and GC1 cells had significantly decreased at concentrations of more than 50 lM and 100 lM BPA, respectively, suggesting that Neuro2a cells are more sensitive than GC1 cells to BPA. We therefore used BPA at concentrations less than 50 and 100 lM for administration to Neuro2a and GC1 cells, respectively, in the following experiments. Expression levels of DJ-1 after administration of BPA for 24 and 48 h in cells were then determined by Western blotting (Figs. 2B and 2C) . Results showed that expressions of DJ-1 in Neuro2a and GC1 cells increased with BPA administration in time-and dose-dependent manners, and the expression levels were 2.5-fold higher than in vehicle control cells.
Production of ROS in Neuro2a and GC1 Cells Induced by BPA Administration ROS levels in Neuro2a and GC1 cells after administration of BPA were measured by using flow cytometry (Fig. 3) . At various times after administration of 50 or 100 lM BPA, cells were reacted with DCFH-DA, which detects various ROS (Kobzik et al., 1990) . BPA was found to induce the production of ROS in Neuro2a cells in a time-dependent manner (Fig. 3A) . In GC1 cells, on the other hand, ROS production peaked at 12 h after BPA administration and decreased with time (Fig. 3B) . Furthermore, to measure highly reactive oxygen species (hROS) such as hydoxyradical (ÁOH) and peroxynitrite (ONOO ÿ ), cells that had been administered BPA were reacted with HPF, which only detects hROS (Setsukinai et al., 2003) . H 2 O 2 added to both Neuro2a and GC1 cells at a concentration of 100 lM for 1 h was not detected by HPF (Figs. 3C and 3D) . BPA, on the other hand, was found to generate hROS production in both Neuro2a and (Figs. 3C and 3D) . The results indicate that BPA induces the production of various ROS, including hROS, in Neuro2A and GC1 cells.
GCI cells at 48 h after administration
pI Shift of DJ-1 in Neuro2a and GC1 Cells Induced by BPA Administration
As described in the introductory section, two types of modification, sumoylation and oxidation, occur on DJ-1. Various oxidized forms of DJ-1 have been found in in vitro cultured cells after oxidative stress (Kinumi et al., 2004; Mitsumoto et al., 2001; Mitsumoto and Nakagawa, 2001) , and DJ-1 has been found to eliminate ROS by oxidizing DJ-1 itself in vitro and in vivo (Taira et al., 2004b) . We have further found that of three cysteines in DJ-1, C106 was first oxidized, and other two cysteines, C46 and C53, were then oxidized by using LC-MS and LC-MS/MS analyses (Kinumi et al., 2004) . pI shift of DJ-1, which indicates oxidation of DJ-1, is thought to be important for DJ-1 to exert its functions.
Proteins were extracted from Neuro2a and GC1 cells at various times after administration of BPA, separated on isoelectric focusing gels, and analyzed by blotting with an anti-DJ-1 antibody (Figs. 4A and 4B, upper panels) . The same aliquots of proteins on filters were also reacted with an antiactin antibody to show loading controls, and intensities of bands were measured by an infrared imaging system (Figs. 4A and 4B in lower panels, 4C and 4D). The results showed that the amounts of oxidized DJ-1 in both Neuro2a and Gc1 cells increased with BPA administration in time-and dose-dependent manners (Figs. 4A and 4B ). The rate of oxidized DJ-1/ unoxidized DJ-1 was significantly increased at 48 h after administration of 50 lM BPA in Neuro2a cells and at 24 h after administration of 100 lM BPA in GC1 cells (Figs. 4C and 4D ), indicating that BPA stimulates oxidization of DJ-1 in Neuro2a and GC1 cells.
Change in Localization of DJ-1 in Neuro2a and GC1 Cells
Following BPA Administration DJ-1 has been shown to be localized both in the cytoplasm and nucleus and to be translocated from the cytoplasm to nucleus upon mitogen stimulation (Nagakubo et al., 1997) and UV irradiation (Shinbo et al., 2005a) . Recent studies have also shown that some DJ-1 is also localized in mitochondria (Blackinton et al., 2005; Canet-Aviles et al., 2004; Jin et al., 2005; Li et al., 2005; Shinbo et al., in press ). We therefore examined the localization of DJ-1 after administration of BPA to cells. Neuro2a and GC1 cells that had been administered BPA were stained with MitoTrakker-Green, which stains mitochondria, and with MitoSOX-Red, which is a mitochondrial O ÿ 2 indicator. MitoSOX-Red is permealized into cells and selectively targeted to mitochondria, in which MitoSOX-Red is oxidized by O ÿ 2 but not by other ROS (see manufacturer's homepage, http://probes.invitrogen.com/lit/bioprobes47/bp47_5. pdf). Cells were also reacted with a rabbit anti-DJ-1 polyclonal antibody and then with a Cy5-conjugated anti-rabbit IgG and were visualized under a confocal laser microscope. These reactions give green, red, and blue colors, respectively, and these images were merged (Figs. 5A and 5B). DJ-1 was found to be localized in the cytoplasm and nucleus without BPA or with vehicle administration in Neuro2a and GC1 cells as reported in other cell types (Nagakubo et al., 1997; Shinbo et al., 2005a) . After BPA administration, on the other hand, expression levels of DJ-1 were increased in both Neuro2a and GC1 cells concomitant with an increase in signals of O It is interesting that the intensity of green fluorescence of MitoTracker-Green decreased in Neuro2a and GC1 cells that had been administered 50 lM BPA and 100 lM BPA for 48 h, suggesting that ROS compromised the mitochondria. To explore this possibility, expressions of a 20-kDa subunit of mitochondrial complex I in cells were examined by Western blotting with an anti-20-kDa subunit antibody, and intensities of bands were quantified. The results showed that levels of the 20-kDa subunit of mitochondrial complex 1 in both Neuro2a and GC1 cells decreased with BPA administration in a   FIG. 3 . Production of ROS in cultured cell induced by BPA administration. Neuro2a (A) and GC1 cells (B) were administered 50 and 100 lM BPA, respectively. At various times after administration, cells were treated with 10 mM DCFH-DA for 30 min, and levels of ROS were analyzed by flow cytometry. To detect hROS produced in cells, Neuro2a (C) and GC1 cells (D) were similarly administered BPA. At 48 h after administration, cells were treated with 10 mM HPF for 30 min, and levels of hROS were analyzed by flow cytometry. Cells were added with 100 mM H 2 O 2 for 1 h, and their hROS levels were also analyzed. Amounts of fluorescences were quantified and were shown in an insert or beside of each figure. Experiments were carried out more than five times. dose-dependent manner (Figs. 5E and 5F). Moreover, the increased expression level of DJ-1 was found to be localized on the damaged mitochondria (see the merged figures, in which the color changed to white yellow). These results suggest that increased O ÿ 2 produced by BPA compromises mitochondria and induces DJ-1 expression and that some of DJ-1 is localized in the injured spots.
Dysfunction of Mitochondrial Complex 1 in Cells Induced by BPA Administration
Dysfunction of mitochondria is thought to be responsible for the onset of neurodegenerative disorders, including PD, and DJ-1 is a causative gene of familial PD. Dysfunction of mitochondrial complex 1 has been found in PD patients, and rats or mice that had been administered drugs that injure mitochondrial complex 1 have been reported to show PD-like phenotypes, including dopaminergic neuronal cell death (see recent reviews, Corti et al., 2005; Shen and Cookson, 2004; Tretter et al., 2004) . Moreover, since we have found that BPA induced production of ROS in the mitochondria of Neuro2a and GC1 cells and injured the mitochondria, activity and expression levels of subunits of mitochondorial complex 1 were examined. Neuro2a and GC1 cells were administered various concentrations of BPA. At 48 h after administration, mitochondria-rich fractions were prepared, and their activities and expression levels of subunits of complex 1, including subunits of 39, 30, and 20 kDa, were analyzed by Western blotting with anti-complex 1 subunit antibodies (Fig. 6) . The expression of DJ-1 in mitochondrialrich fractions was also examined. While the expression levels of all of the subunits of mitochondrial complex 1 decreased with BPA administration in a dose-dependent manner, complex I activity level was found to increase in Neuro2a cells or to hardly change in GC1 cells at low concentrations of BPA and then to significantly decrease in a dose-dependent manner at high concentrations of BPA (decrease at more than 50 and 100 lM BPA in Neuro2a and GC1 cells, respectively) (Figs. 2, 6A-6D ). It is notable that patterns of complex 1 activities, initial increase and then decrease, paralleled those of DJ-1 expression in cells (Figs. 6E and 6F) . To assess the relationship between DJ-1 expression and complex 1 activity, siRNA targeting the DJ-1 or luciferase gene, which is a nonspecific control, was transfected into Neuro2a and GC1 cells to knock down expression of the respective gene, and activities of complex 1 were measured at 3 days after transfection. Introduction of these siRNAs into cells was confirmed not to affect the expressions of subunits of complex 1 (Figs. 6C and 6D) . Although siRNA against luciferase affected neither the expression of DJ-1 nor the activity of complex 1, siRNA against DJ-1 reduced both the expression level of DJ-1 and activity level of complex 1 to 10% and 70% of those without siRNA in Neuro2a and GC1 cells, respectively (Figs. 6E and 6F, lanes 7-9) . These results suggest that BPA abrogates complex I activity by disrupting complex 1 and that DJ-1-knockdown decreases complex I activity without decrease in complex I expression. The results also suggest that the initial increase in the level of DJ-1 expression upon BPA administration that leads to ROS production plays a role in maintenance of complex 1 activity.
Abrogation of BPA-Induced Cell Death by DJ-1 in Neuro2a and GC1 Cells
To investigate the role of DJ-1 in BPA-induced cell injury, siRNA against DJ-1 was transfected into Neuro2a and GC1 cells using Lipofectamine 2000 to reduce the expression levels of DJ-1 in the cells. siRNA targeting the luciferase gene was used as a negative control, and transfection using Lipofectamine 2000 alone without siRNA was used as a vehicle control. BPA was then administered into cells at 24 h after transfection of siRNA. At 48 h after administration of BPA, cell viabilities were examined by an MTT assay (Fig. 7) . The concentrations of BPA used are those that induce cell death as shown in Figure 2A , 50 and 100 lM into Neuro2a cells and 100 and 200 lM of BPA. We first confirmed that the expression levels of DJ-1 in transfected cells were reduced to 10% of those in nontransfected cells as described in Figures 6E and 6F , and that cell death did not occur after transfection of siRNA into cells without BPA administration (data not shown). Neuro2a and GC1 cells transfected with siRNA against DJ-1 were found to become significantly more susceptible to cell death than those transfected with siRNA against luciferase or with a buffer alone.
To further investigate the role of DJ-1 in BPA-induced cells death, Nero2a and GC1 cells were transfected with an expression vector for DJ-1, pcDNA3-F-DJ-1, using Lipofectamine 2000, and BPA was administered to cells 24 h after transfection. At 48 h after administration of BPA, cell viabilities were examined by an MTT assay (Fig. 7) . Transfection with vector alone, pcDNA3-F, and that without plasmid DNA were used as negative (vector) and vehicle controls. Expression of transfected FLAG-tagged DJ-1 in transfected Neuro2a and GC1 cells was confirmed by Western blotting with an anti-DJ-1 antibody (Figs. 8A and 8B ). In these blottings, relatively equal expression levels of endogenous DJ-1 in Neuro2a and GC1 cells were observed. In contrast to the case of transfection with siRNA into cells, Neuro2a and GC1 cells transfected with DJ-1 were found to become significantly more resistant to cell death than those transfected with a vector or with a buffer alone (Figs. 8C and 8D) . These results suggest that DJ-1 is one of the proteins that prevent BPA-induced cell death in Neuro2a and GC1 cells.
DISCUSSION
Oxidative stresses caused by excess ROS production in mitochondria and microsomes are known to damage nucleic acid, lipid, and protein, resulting in the onset of various diseases, including cancer, infertility, and neurodegenerative diseases such as PD. Chemicals with structures similar to that of BPA have been reported to accumulate in adipose tissues and to be partitioned preferentially into membranes containing interior hydrophobic protein rather than the polar hydrophilic part (Law et al., 1986; Nunez et al., 2001) . Since the mitochondria membrane is composed of this type of protein, BPA is thought to accumulate in the mitochondrial membrane, resulting in an uncoupling of the oxidative phosphorylation, thereby inhibiting complex I activity. The molecular mechanism of ROS production by BPA, however, remains unclear.
In this study, we examined the expression and oxidative levels of DJ-1 after administration of BPA to mice and cultured cells, and we found that expression of DJ-1 was induced by BPA-induced ROS production concomitant with oxidation of DJ-1. We also found that BPA compromised mitochondria, resulting in reduction of the activity of mitochondrial complex 1 and that upon injury of mitochondria by BPA, an elevated expression level DJ-1 was observed on the injured mitochondria FIG. 5 . Localization of DJ-1 after administration of BPA in cultured cells. Neuro2a (A) and GC1 cells (B) were administered 50 and 100 lM BPA. At 48 h after administration, cells were reacted with 500 nM MitoTracker-Green for 40 min, 5 mM MitoSOX-Red for 10 min, and an anti-DJ-1 antibody followed by reaction with an Cy5-conjugated anti-rabbit IgG, and then visualized under a confocal laser microscope. The images were merged (merge). Levels of superoxide (O - 2 ) in mitochondria of Neuro2a (C) and GC1 cells (D) were also measured by flow cytometry, and the amounts of fluorescences quantified were shown under each figure. These experiments were carried out more than five times. Proteins extracted from Neuro2a (E) and GC1 cells (F) at 48 h after administration were analyzed by Western blotting with an anti-20-kDa subunit of a complex I monoclonal antibody and anti-actin antibody. (E) Neuro2a (n ¼ 5). (F) GC1 (n ¼ 5). Asterisks indicate significant difference from the vehicle control; *p < 0.05; **p < 0.01.
ABROGATION OF BPA-INDUCED CELL INJURY BY DJ-1
to restore the activity of complex 1. Since DJ-1 was located in the cytoplasm, nucleus, and mitochondria in various types of cells (Bandopadhyay et al., 2004; Nagakubo et al., 1997; Shendelman et al., 2004; Shinbo et al., 2005a, in press; Wagenfeld et al., 2000; Zhang et al., 2005) , and some DJ-1 was translocated to mitochondria after oxidative stress (Blackinton et al., 2005; Jin et al., 2005; Li et al., 2005) , the localization of DJ-1 in mitochondria in the cells that had been administered BPA was thought to affect BPA-induced ROS production.
The activity of DJ-1 to sustain the activity of complex 1 was, however, observed at 50 and 100 lM BPA in Neuro2a and GC1 cells, respectively, and this activity was lost over these concentrations. Since, at high concentrations of BPA, cells began to die and the amount of DJ-1 also decreased, it is thought that the amount of DJ-1 is not sufficient to sustain the activity of complex 1. Alternatively, although DJ-1 contains three cysteines, and oxidation of a cysteine at amino acid number 106 (C106) is essential for DJ-1 to exert its anti-oxidative stress activity (Taira et al., 2004b; Takahashi-Niki et al., 2004) , oxidation of all three cysteines by excess ROS, which is produced by high doses of BPA, for instance, may result in loss of its activity (Kinumi et al., 2004; Taira et al., 2004b) .
Although DJ-1 is an abundant protein and approximately 5 3 10 5 molecules/cell of DJ-1 is present in cells, it is likely that, in addition to DJ-1, other ROS-scavenging proteins such as superoxide dismutase, glutathione peroxidase and catalase, and proteins belonging to other redox systems participate in protecting cells from BPA-induced cell injury. We have found that drastic changes in expressions of genes, including genes related to stress, apoptosis, oxidative stress, and neurotoxicity, occurred in DJ-1 knockdown and that expressions of some genes were regulated by DJ-1 (Nishinaga et al., in press) , suggesting that in addition to anti-oxidative activity of DJ-1, transcriptional function of DJ-1 toward genes related to stress functions is important.
In this study, levels of ROS production peaked at 12 h after BPA administration in GC1 cells and then decreased at 24 and 6 . Dysfunction of mitochondria in cultured cell induced by BPA administration. Neuro2a (A) and GC1 cells (B) were administered various concentrations of BPA. At 48 h after administration, mitochondria-rich fractions were prepared from cells, and complex 1 activities were measured using 70 lg proteins as described in Materials and Methods. Twenty lg of proteins were analyzed by Western blotting to detect 39-, 30-, and 20-kDa subunits of complex 1. Intensities of bands were quantified as described in Materials and Methods, and relative expression of each subunit to that of untreated cells (untreated) at 0 h is also shown (C, Neuro2a; D, GC1). DJ-1 expression in Neuro2a (E) and GC1 cells (F) that had been administered BPA was analyzed by Western blotting with an anti-DJ48 h. ROS production in Neuro2A cells, however, continued to occur during these periods. In the kidney, liver, and testis, an isoform of UDP-glucuronosyltransferase (UGTs) has been shown to metabolize BPA to BPA-glucuronide (Reinhechel et al., 1995) . Although the presence of UGTs in GC1 cells has not been examined, BPA produced at 12 h after BPA administration might be metabolized in GC1 cells.
The present study showed that BPA induced production of various ROS, including highly reactive hydroxy radicals, and ROS have been shown to attack mitochondrial complex I (Yokota et al., 1999) . Nakagawa and Toyama reported reduction of complex 1 activity after incubation of a mitochondria-rich fraction with BPA in vitro, but degradation of mitochondria and production of ROS were not examined (Nakagawa and Toyama, 2000) . Since the present study showed that BPA induces ROS production and inhibits complex I activity by disrupting complex I, it would be interesting to examine whether degradation of complex 1 by BPA also occurs in vitro using an electron microscopy and whether this degradation is restored by DJ-1.
Environmental factors are thought to trigger the onset of PD. Several neurotoxins, including 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTT), rotenone, 6-hydroxydopamine (6-OHDA), and a metabolite of dopamine itself, have been reported to injure mitochondria, resulting in dopaminergic neuron death (Jenner, 2003) . Recently, BPA has been reported to affect movement and to induce dopaminergic neuron death when BPA was administered to embryonal mice and into the substantia nigra of adult rats, respectively, though ROS levels were not examined (Kabuto et al., 2004; Mizuo et al., 2004; Suzuki et al., 2003) . BPA has been detected in several tissues and the blood serum of humans (Ikezuki et al., 2002; Schonfelder et al., 2002) and accumulates in adipose tissue and membranes, creating the potential for long-term exposure of humans to a low dose of BPA. Human exposure to PBA, and our resent results, suggest that BPA could be a risk factor for the onset of familial and sporadic PD. Furthermore, there are many factors in the environment that cause oxidative stress to humans, including smoking, UV light, alcohol, and environmental contaminants. These factors, including BPA, might act by themselves or in combination as risk factors for diseases such as cancer, infertility, and neurodegenerative diseases.
Since the activity of mitochondrial complex I was significantly diminished by siRNA targeting DJ-1 in the cells of this study, it is possible that DJ-1 has a novel function to maintain complex I activity. In DJ-1-knockdown cells, complex 1 was still intact. Although the precise molecular basis of this reaction is not clear at present, it is important to clarify its mechanism.
